I agree that this site is using cookies. You can find further informations here.
X
Talukder, Rafee
22  results:
Search for persons X
?
1

Frequency and Nature of Genomic Alterations in ERBB2-Altere..:

Leary, Jacob B. ; Enright, Thomas ; Bakaloudi, Dimitra Rafailia...
Targeted Oncology.  19 (2024)  3 - p. 447-458 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Treatment Rechallenge With Immune Checkpoint Inhibitors in ..:

Makrakis, Dimitrios ; Bakaloudi, Dimitra Rafailia ; Talukder, Rafee...
Clinical Genitourinary Cancer.  21 (2023)  2 - p. 286-294 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Response and Outcomes of Maintenance Avelumab After Platinu..:

Bakaloudi, Dimitra Rafailia ; Talukder, Rafee ; Lin, Genevieve Ihsiu...
Clinical Genitourinary Cancer.  21 (2023)  5 - p. 584-593 , 2023
Link: https://doi.org/10.1016/..
 
?
4

The Evolving Therapeutic Landscape and Role of Enfortumab V..:

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA ; Department of Medicine, Division of Oncology, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA ; Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY, USA...
Oncology & Haematology.  19 (2023)  1 - p. 27 , 2023
Link: https://doi.org/10.17925..
 
?
5

Selective immune suppression using interleukin-6 receptor i..:

Fa'ak, Faisal ; Buni, Maryam ; Falohun, Adewunmi...
Journal for ImmunoTherapy of Cancer.  11 (2023)  6 - p. e006814 , 2023
Link: https://doi.org/10.1136/..
 
?
6

Role of Underlying Liver Pathology in the Development of Im..:

Storm, Erica M. ; Makrakis, Dimitrios ; Lin, Genevieve I....
Targeted Oncology.  18 (2023)  4 - p. 601-610 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Association of the Time to Immune Checkpoint Inhibitor (ICI..:

Talukder, Rafee ; Makrakis, Dimitrios ; Lin, Genevieve Ihsiu...
Clinical Genitourinary Cancer.  20 (2022)  6 - p. 558-567 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Association Between Sites of Metastasis and Outcomes With I..:

Makrakis, Dimitrios ; Talukder, Rafee ; Lin, Genevieve Ihsiu...
Clinical Genitourinary Cancer.  20 (2022)  5 - p. e440-e452 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Response and Outcomes to Immune Checkpoint Inhibitors in Ad..:

Talukder, Rafee ; Makrakis, Dimitrios ; Diamantopoulos, Leonidas N....
Clinical Genitourinary Cancer.  20 (2022)  2 - p. 165-175 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Genomic trajectory in leukemogenesis of myeloproliferative ..:

Chen, Yujie ; Talukder, Rafee ; Merritt, Brian Y....
BMC Medical Genomics.  14 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
11

Association of prior local therapy and outcomes with progra..:

Makrakis, Dimitrios ; Talukder, Rafee ; Diamantopoulos, Leonidas N....
BJU International.  130 (2021)  5 - p. 592-603 , 2021
Link: https://doi.org/10.1111/..
 
?
12

Efficacy of enfortumab vedotin in advanced urothelial cance..:

Koshkin, Vadim S. ; Henderson, Nicholas ; James, Marihella...
Cancer.  128 (2021)  6 - p. 1194-1205 , 2021
Link: https://doi.org/10.1002/..
 
?
13

Selective immune suppression using interleukin-6 receptor i..:

Fa'ak, Faisal ; Buni, Maryam ; Falohun, Adewunmi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277540/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Response and Outcomes to Immune Checkpoint Inhibitors in Ad..:

Talukder, Rafee ; Makrakis, Dimitrios ; Diamantopoulos, Leonidas N...
qt9mh6t47q.  , 2022
Link: https://escholarship.org..
 
?
15

Association of prior local therapy and outcomes with progra..:

Makrakis, Dimitrios ; Talukder, Rafee ; Diamantopoulos, Leonidas N...
qt8678m8j9.  , 2022
Link: https://escholarship.org..
 
1-15